<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-157317</identifier>
<setSpec>1887-8571</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Possitive assesment of drugs: March, April and May 2016</dc:title>
<dc:description xml:lang="en">The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in March, April and May of 2016, and considered of interest to the healthcare profesional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product (AU)</dc:description>
<dc:creator>García Luque, A</dc:creator>
<dc:creator>Prats Olivan, P</dc:creator>
<dc:creator>Aparicio Hernández, R</dc:creator>
<dc:creator>Sánchez López, P</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Se reseñan los medicamentos evaluados y con dictamen positivo por la comisión de expertos de la Agencia Española de Medicamentos y Productos Sanitarios o de la Agencia Europea del Medicamento hechos públicos en marzo, abril y mayo de 2016. Se trata de opiniones técnicas positivas previas a la autorización y puesta en el mercado del medicamento (AU)</dc:description>
<dc:source>Sanid. mil;72(3): 200-208, jul.-sept. 2016.</dc:source>
<dc:identifier>ibc-157317</dc:identifier>
<dc:title xml:lang="es">Evaluación positiva de medicamentos: marzo/abril/mayo 2016</dc:title>
<dc:subject>^d55900</dc:subject>
<dc:subject>^d55897</dc:subject>
<dc:subject>^d23109</dc:subject>
<dc:subject>^d30745</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d2478</dc:subject>
<dc:subject>^d24613^s22079</dc:subject>
<dc:subject>^d4403^s22074</dc:subject>
<dc:type>article</dc:type>
<dc:date>201609</dc:date>
</metadata>
</record>
</ibecs-document>
